⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a
very recent recall may be missing. Everything shown is accurate as of the last checked time on this page —
for anything time-critical, confirm with the official sources linked below.
FDAClass II · Drug · Recalled June 24, 2026
Med Pride recall — Dabur India Limited
Hazard: CGMP Deviations; deficiencies observed during FDA inspection
Class II: may cause temporary or medically reversible health consequences.
View the official FDA enforcement record (openFDA) ↗
- Official recall ID
- D-0636-2026
- Brand
- Dabur India
- Classification
- Class II
- Units affected
- 4374 tubes
- Recall status
- Ongoing
- Initiated
- Voluntary: Firm initiated
Description
Med Pride, Bacitracin Zinc Ointment, 500 units, 1oz (28.3g) tubes, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 30354 8.
Affected products
Companies & origin
- Recalling firm location
- Dadra And Nagar Haveli, India
- Firm address
- 225 - 4 - 1 Saily Village, Survey No, N/A
Identifying details (verbatim from the notice)
- Product codes / lots
- Lot# 001, 002, 003, 004, 005, 006, 010, 011, 012, 013, 014, 016, 017, 018, 019, 020, Within Expiry.
- Distribution
- US Nationwide.
- Firm notified the public via
- E-Mail
- FDA event ID
- 99137
- Recall initiated
- June 2, 2026
- FDA classified
- June 26, 2026
- FDA report date
- June 24, 2026
Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim;
the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.
Report a data error on this page